These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 834821)

  • 1. Clinical evidence for neurochemical adaptation to psychotrophic drugs [proceedings].
    Post RM; Goodwin K
    Psychopharmacol Bull; 1977 Jan; 13(1):47-9. PubMed ID: 834821
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward a biochemical classification of depression.
    van Praag HM
    Adv Biochem Psychopharmacol; 1974; 11(0):357-68. PubMed ID: 4845704
    [No Abstract]   [Full Text] [Related]  

  • 3. [The probenecid test and its application to research in schizophrenia].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):252-5. PubMed ID: 6085620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 5. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evidence for neurochemical adaptation to psychotropic drugs.
    Goodwin FK; Post RM; Sack RL
    Adv Biochem Psychopharmacol; 1975; 13():33-45. PubMed ID: 239532
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurobiologocal mechanisms of presynaptic metabolic adaptation and their organization: implications for a pathophysiology of the affective disorders.
    Mandell AJ
    Adv Biochem Psychopharmacol; 1975; 13():1-32. PubMed ID: 240255
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical diagnosis of dopaminergic disturbances in paediatric patients: analysis of cerebrospinal fluid homovanillic acid and other biogenic amines.
    Marín-Valencia I; Serrano M; Ormazabal A; Pérez-Dueñas B; García-Cazorla A; Campistol J; Artuch R
    Clin Biochem; 2008 Nov; 41(16-17):1306-15. PubMed ID: 18790694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on psychotropic drugs. XX. Effects of 1-methyl-5-o-chlorophenyl-7-ethyl-1,2-dihydro-3H-thieno[2,3-e][1,4]diazepin-2-one (Y-6047) on the metabolism of biogenic amines.
    Nakanishi M; Setoguchi M
    Arzneimittelforschung; 1972 Nov; 22(11):1914-8. PubMed ID: 4267010
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
    Arai M
    Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
    [No Abstract]   [Full Text] [Related]  

  • 12. CSF monoamine metabolites during treatment with mianserin or amitryptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; van Dorth R
    Adv Biochem Psychopharmacol; 1982; 32():249-56. PubMed ID: 6178263
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding biochemical pathology of depressive illness. An overview.
    Jain M; Jain KM
    Psychiatr Neurol Neurochir; 1973; 76(4):285-95. PubMed ID: 4354410
    [No Abstract]   [Full Text] [Related]  

  • 14. Biogenic amines in cerebrospinal fluid and plasma of patients with dementia of Alzheimer type.
    Pinessi L; Rainero I; De Gennaro T; Gentile S; Portaleone P; Bergamasco B
    Funct Neurol; 1987; 2(1):51-8. PubMed ID: 3678940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects.
    Bertilsson L; Asberg M
    Adv Biochem Psychopharmacol; 1984; 39():27-34. PubMed ID: 6205559
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of clozapine on the excretion of 3-methoxy-4-hydroxy-phenylglycol, homovanillic acid and 5-hydroxy-indole acetic acid in urine and cerebrospinal fluid].
    Ackenheil M; Beckmann H; Hoffmann G; Markianos E; Nyström I; Raese J
    Arzneimittelforschung; 1974 Jul; 24(7):984-7. PubMed ID: 4408052
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of probenecid and large dose amphetamine administration on cerebrospinal fluid homovanillic acid.
    Angrist BM; Wilk S; Gershon S
    Biol Psychiatry; 1974 Feb; 8(1):113-4. PubMed ID: 4815338
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on psychotropic drugs. XVII. Effects of 3-chloro-5-(3-(4-piperidino-4-carbamoyl-piperidino)-propyl)-10,11-dihydro-5(H)-dibenz-(b,f)-azepine dihydrochloride monohydrate (Y-4153) on the metabolism of biogenic amines.
    Nakanishi M; Setoguchi M
    Arzneimittelforschung; 1973 Jun; 23(6):806-10. PubMed ID: 4740766
    [No Abstract]   [Full Text] [Related]  

  • 19. [Examination of CSF: the probenecid test. Its value and limits in the exploration of cerebral monoamines in man].
    Warter JM; Coquillat G; Renaud B; Borg J; Collard M; Rohmer F
    Rev Otoneuroophtalmol; 1975; 47(5):417-8. PubMed ID: 2964
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical application of the probenecid test for measurement of monoamine turnover in the CNS.
    Faull KF; Kraemer HC; Barchas JD; Berger PA
    Biol Psychiatry; 1981 Sep; 16(9):879-99. PubMed ID: 6170352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.